M1 Kliniken AGSTU:M12 +1.31%91 FCF Margin % is 10.44% as of Dec. 2025, which is 117% above its 10-year median of 4.82. GuruFocus rates STU:M12 with a GF Score™ of 91/100 and a GF Value™ of €15.98 (Modestly Overvalued). The stock has 3 warning signs investors should review. Among 118 Medical Distribution companies, M1 Kliniken AG ranks better than 89.83% on this metric.
The historical rank and industry rank for M1 Kliniken AG's FCF Margin % or its related term are showing as below:
STU:M12'
s FCF Margin % Range Over the Past 10 Years
Min: -8.7 Med: 4.82 Max: 19.32
Current: 10.39
During the past 12 years, the highest FCF Margin % of M1 Kliniken AG was 19.32%. The lowest was -8.70%. And the median was 4.82%.
STU:M12's FCF Margin % is ranked better than 89.83% of 118
companies
in the Medical Distribution industry
Industry Median: 1.06
vs STU:M12: 10.39
M1 Kliniken AG FCF Margin % Related Terms
M1 Kliniken AG FCF Margin % Historical Data
* Premium members only.
The historical data trend for M1 Kliniken AG's FCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, M1 Kliniken AG's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
M1 Kliniken AG FCF Margin % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, M1 Kliniken AG's FCF Margin % distribution charts can be found below:
* The bar in red indicates where M1 Kliniken AG's FCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
M1 Kliniken AG (STU:M12) has a FCF Margin % of 10.44% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on M1 Kliniken AG and its competitors. This is 117% above median its historical median of 4.82. According to the industry distribution chart, M1 Kliniken AG ranks #12 out of 118 companies in the Medical Distribution industry, placing it in the top 10.2%.
Is M1 Kliniken AG's FCF Margin % too high?
M1 Kliniken AG's current FCF Margin % of 10.44% is 117% above median its 10-year median of 4.82. The Medical Distribution industry median FCF Margin % is 1.06. M1 Kliniken AG's value of 10.44% is 884.9% above this industry median. Based on the distribution chart, M1 Kliniken AG ranks #12 out of 118 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, M1 Kliniken AG has a GF Score™ of 91/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does M1 Kliniken AG's FCF Margin % compare to MCK and COR?
According to the Medical Distribution industry distribution chart, M1 Kliniken AG ranks #12 out of 118 companies for FCF Margin %. This places M1 Kliniken AG in the top 10% of its industry — outperforming the majority of peers. The industry median FCF Margin % is 1.06. M1 Kliniken AG's value of 10.44% is 884.9% above this benchmark. While the company's 10-year median is 4.82 vs. the industry median of 1.06, M1 Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Distribution company?
The median FCF Margin % among Medical Distribution companies is 1.06, based on 118 companies in the industry. Companies in the top quartile (top 25%) have a FCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. M1 Kliniken AG's current FCF Margin % of 10.44% is 884.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on M1 Kliniken AG and its competitors. For the Medical Distribution industry, the median FCF Margin % is 1.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. M1 Kliniken AG's current FCF Margin % is 10.44%, which is 117% above median its own 10-year median of 4.82. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is M1 Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, M1 Kliniken AG (STU:M12) is currently considered Modestly Overvalued. The stock's GF Value™ is €15.98, compared to a current price of €18.54 — trading 16% above its estimated fair value. The current FCF Margin % is 10.44%, which is 117% above median its 10-year median of 4.82 and 884.9% above the Medical Distribution industry median of 1.06. M1 Kliniken AG's overall GF Score™ is 91/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For M1 Kliniken AG (STU:M12), the current FCF Margin % is 10.44% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is M1 Kliniken AG (STU:M12) Overvalued in 2026?
Based on GuruFocus' analysis, M1 Kliniken AG stock appears to be overvalued.
The current stock price of €18.54 is trading 16% above its estimated GF Value™ of €15.98.
GuruFocus considers M1 Kliniken AG to be Modestly Overvalued.
Key valuation signals for STU:M12:
FCF Margin %: 10.44% (117% above median its 10-year median of 4.82)
GF Value™: €15.98 vs. price of €18.54 (16% above fair value)
Industry Position: 884.9% above the Medical Distribution median (#12 of 118)
No single metric tells the full story. See the STU:M12 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
M1 Kliniken AG operates in the growing market of aesthetic medicine and plastic surgery and provides aesthetic medical treatments in the self-pay segment. It operates through Beauty and Trade segments. Its activities are focused on providing aesthetic medical treatment. In addition to medical aesthetic treatments, the company also develops and markets pharmaceutical, medical, and medical technology products for aesthetic surgery and cosmetic dermatology. Some of the treatments offered by the group are lip under injection, eyebrow lift, tummy tuck, breast reduction, sweat treatment, liposuction, and others. The organization conducts its business operations in Germany. The majority of its revenue is derived from the Trade segment.
91GF Score
Get the complete analysis for STU:M12
FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:M12 has been successfully added to your 
